US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NYSE
RiverNorth Opportunistic Municipal Income Fund Inc (RMI) 銘柄情報

RiverNorth Opportunistic Municipal Income Fund Inc (RMI)

15.21

-0.13

(-0.85%)

終了 6月16日 5:00AM

15.215

0.00

(0.00%)

取引時間後: 5:25AM

RiverNorth Opportunistic Municipal Income Fund Inc (RMI) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

15.21

( -0.85% )

買値

-

売値

-

出来高

21,391

15.16 日の範囲 15.35

13.71 52 週間の範囲 16.36

前日終値

15.34

始値

15.28

時刻

最終取引時間

平均取引量 (3 か月)

16,037

財務取引量

US$ 325,627

VWAP

15.2226

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

RiverNorth Closed-End Funds Declare Monthly Distributions

In accordance with the RiverNorth closed-end funds (the “Funds”) level distribution policies, the Funds have established the distribution dates...

Form N-CSRS - Certified Shareholder Report, Semi-Annual

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

RiverNorth Closed-End Funds Declare Monthly Distributions

In accordance with the RiverNorth closed-end funds (the “Funds”) level distribution policies, the reset distribution rates have been proposed for...

Form 4 - Statement of changes in beneficial ownership of securities

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.19	-1.23376623377	15.4	15.5	15.03	9431	15.28520634	CS
4	-0.17	-1.10533159948	15.38	15.575	14.93	11320	15.22129604	CS
12	-0.48	-3.05927342256	15.69	15.89	14.52	16037	15.37204512	CS
26	0.71	4.89655172414	14.5	16.36	14.22	27606	15.21213263	CS
52	0.85	5.91922005571	14.36	16.36	13.71	31733	14.67132208	CS
156	-0.72	-4.5197740113	15.93	17.37	13.05	24143	15.06769241	CS
260	-8.29	-35.2765957447	23.5	24.23	13.05	21999	16.16865858	CS

RMI - Frequently Asked Questions (FAQ)

What is the current RiverNorth Opportunistic Municipal Income Fund Inc share price?

The current share price of RiverNorth Opportunistic Municipal Income Fund Inc is US$ 15.21

What is the 1 year trading range for RiverNorth Opportunistic Municipal Income Fund Inc share price?

RiverNorth Opportunistic Municipal Income Fund Inc has traded in the range of US$ 13.71 to US$ 16.36 during the past year

biotechinvestor1

biotechinvestor1 4分前

Total nonsense! I have no interest in educating you.

Nemesis18

Nemesis18 4分前

She'll probably move to somewhere without any extradition treaty once the plug is finally pulled on this 'cancer vaccine' scam.?

price_and_volume

price_and_volume 7分前

Gonna have to bump the A/S then...
He said recently that they are looking at another acquisition...and he will dilute with shares to get it. Agreed - I posted the same, "where's the finance coming from for acquisitions?"...

Supposed 400MM shares going to $GTVH (believe it when

StockItOut

StockItOut 7分前

WKSP Weekly chart: https://schrts.co/IIIuZpgy

CelestialSage6

CelestialSage6 8分前

I understand that Halozyme has not signed any exclusive agreements regarding treatments or indications related to Dupixent, so why is Sanofi collaborating with Alteogen?

Also, Halozyme's mdase patent is being invalidated due to Merck. Alteogen's technology is more advanced than Halozy

Wolf-man jack

Wolf-man jack 10分前

WQLF SAYS: Have Mercy WQLF ahoooooo

Q: Why hasn't CV SCIENCES been accepted in the CMS Medicare Pilot Program?

Ai Generated:

CV Sciences has not been "accepted" into the CMS Medicare Pilot Program because the pilot is a provider-led incentive, not a pro

price_and_volume

price_and_volume 11分前

What reasonable expectation is there of PPS responding?
whether management can successfully execute on the vision they have laid out. Nobody cares about "the company" or "the management" or "their vision" or your two-bit-MBA-tutorials-in-a-post.

Enough of all that garbage.

mrwrn2010

mrwrn2010 14分前

Disagree. The outcome of OxyContin litigation was unknown 9 months to a year ago. You can guess at a variety of outcomes, sure, but it’s not certain. Same thing with human trials - we don’t have positive trial results for anything in the pipeline until we have them. What passes in vitro may not pass

PEACHMAN

PEACHMAN 16分前

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177680761

IFUS STRONG

price_and_volume

price_and_volume 17分前

I get that, but that's not what I asked.

I'm not bullying you or accusing you of pumping.

You repeatedly point out what you consider to be nefarious shenanigans, so I asked: PPS hasn't effectively changed in THREE YEARS , other than a few short days 1 year ago this wee

Homework.Investwell

Homework.Investwell 24分前

2017 Northwest Biotherapeutics, Inc.
4800 Montgomery Lane, Suite 800

Suite 800 is empty....🤔

Linda lives in Missouri now but headquarters could be moved anywhere...or will they need it?

I think we're going to find out by the end of the sum

Mdk1

Why this paper is highly interesting for Lightwave Logic (GROK)
This is a top-scored paper that strongly validates Lightwave Logic’s Perkinamine™ chromophore series 3 as a leading electro-optic material for next-generation datacenter optics.

Key Reasons Why It Matters:

janice shell

janice shell 33分前

Now that's a real head-scratcher! But shorts have to be smart, so I'd say torso and head.

gitreal

gitreal 35分前

Anyone with half a Brian can see this company is being crazy shorted!

Which half? Torso and head?

HyGro

NWBO could file an FDA application anytime but they haven't and have shown no intent to do so. Instead they are just burning more shareholder cash and if approved, will lose money on every dose because NICE will hammer the reimbursement down below Advent's costs. NWBO will lose money and collaps

US Market News

US Market News 40分前

TotalEnergies SE: Disclosure of Transactions in Own SharesJune 16, 2026 2:00 AM
Business Wire Regulatory News In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share

HyGro

Sorry, not enough. NWBO won't make any profit selling in the UK. NICE hates personalized oncology treatments and won't pay enough for NWBO to make a profit.
That's what counts. And NWBO will go under or just become Advent Contract Manufacturer. They have no cash or credit to fund any sub

biotechinvestor1

biotechinvestor1 44分前

Don’t start spazzing again, Alteogen circus clown. The Sanofi news is old.
Once Merck settles/licenses from Halozyme, Sanofi and all others will follow.
Your Alteogen stole IP from Halozyme and will pay a price for it. You can count on it.
The companies who have signed with Alte

Steady_T

Steady_T 45分前

Your theory will be put to the test after UK approval. I give it 6 months as a guess.

HyGro

What's true is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How many years are you going to wait to find out???

HyGro

What's True is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How long are you going to wait to find out???

Mdk1

Google Scholar alert - new article: "A Comparison of Plasmonic Modulator Structures in the O- and C-Band for the 400G/Lane IM/DD Era"
>>> " In ALL cases, the same electro-optic organic material, Lightwave Logic’s PerkinamineTM
chromophore series 3, was used " !
https://ieeexplor

CelestialSage6

CelestialSage6 52分前

Stop talking nonsense. Sanofi is conducting clinical trials using Alteogen's technology; what are your thoughts on this? Did you sense a crisis for Halozyme?

biotechinvestor1

biotechinvestor1 55分前

I love it when Alteogen fanboys post on this board. Nearly every time they show up, Halozyme has a run up.

DR_rugby

DR_rugby 56分前

Prophecy is coming

https://www.cnbc.com/2026/06/16/boj-rate-hike-historic-inflation.html

Japanese rates are going higher

Yen is yet to be stabilize

The great unwinding is coming soon

GLTA

RiverNorth Opportunistic...

Series 1A Mtg Backed Flo...

United States Cellular

US Dollar vs CNY

Motive Capital Corp II

Investec Bnk 23

XS2717987502 20281229 33...

Philippine Metals

ProShares UltraShort S&P...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。